Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2024	Oct. 01, 2023
Cash flows from operating activities:
Net income	$ 146,860	$ 157,502
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (exclusive of amortization of cloud computing arrangements shown separately below)	110,006	101,258
Amortization of cloud computing arrangements	10,637	7,692
Share-based compensation	18,491	16,769
Impairment of long-lived assets	2,873	513
Deferred income tax	(465)	(502)
Non-cash rental expense, net	31,973	30,724
Change in operating lease liabilities	(36,461)	(35,319)
Net receipt of deferred vendor incentives	1,449	4,007
System optimization (gains), net	(573)	(119)
Distributions received from joint ventures, net of equity in earnings	2,055	1,349
Long-term debt-related activities, net	5,609	7,310
Cloud computing arrangements expenditures	(10,583)	(25,154)
Changes in operating assets and liabilities and other, net	4,810	3,495
Net cash provided by operating activities	286,681	269,525
Cash flows from investing activities:
Capital expenditures	(52,361)	(55,689)
Franchise development fund	(21,040)	(1,947)
Dispositions	3,222	280
Notes receivable, net	1,383	1,825
Net cash used in investing activities	(68,796)	(55,531)
Cash flows from financing activities:
Repayments of long-term debt	(21,937)	(61,280)
Repayments of finance lease liabilities	(15,421)	(16,947)
Repurchases of common stock	(60,056)	(142,413)
Dividends	(153,411)	(157,871)
Proceeds from stock option exercises	4,651	9,113
Payments related to tax withholding for share-based compensation	(4,395)	(3,827)
Net cash used in financing activities	(250,569)	(373,225)
Net cash used in operations before effect of exchange rate changes on cash	(32,684)	(159,231)
Effect of exchange rate changes on cash	(1,603)	307
Net decrease in cash, cash equivalents and restricted cash	(34,287)	(158,924)
Cash, cash equivalents and restricted cash at beginning of period	588,816	831,801
Cash, cash equivalents and restricted cash at end of period	$ 554,529	$ 672,877